TRAF6 overexpression in hepatocytes promotes ubiquitination-dependent activation of ASK1, contributing to the pathogenesis of hepatic fibrosis during the progression of nonalcoholic steatohepatitis (NASH) (Wang et al., 2020). Here, MAP3K5 is linked to metabolic dysfunction-associated steatohepatitis.